Evidence map›Paper›PMID 38239489›Full record

ReviewFrontiers in aging neuroscience2023

Exploring the complexities of 1C metabolism: implications in aging and neurodegenerative diseases.

Ayman Bou Ghanem, Yaman Hussayni, Raghid Kadbey, Yara Ratel, Shereen Yehya, Lara Khouzami, Hilda E Ghadieh, Amjad Kanaan, Sami Azar, Frederic Harb

Open access · goldAbstract readReview
In one paragraph

Review in Frontiers in aging neuroscience, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
4.7field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Monoterpene-rich essential oil fromToxicology research · 2025
    Article
  9. Review
  10. Article
  11. Review
  12. Review
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 2 countries.

Ayman Bou Ghanem *Faculty of Medicine and Medical Sciences, University of Balamand, Tripoli, Lebanon.
Yaman Hussayni *Faculty of Medicine and Medical Sciences, University of Balamand, Tripoli, Lebanon.
Raghid Kadbey *Faculty of Medicine and Medical Sciences, University of Balamand, Tripoli, Lebanon.
Yara Ratel *Faculty of Medicine and Medical Sciences, University of Balamand, Tripoli, Lebanon.
Shereen Yehya *Faculty of Medicine and Medical Sciences, University of Balamand, Tripoli, Lebanon.
Lara KhouzamiCollege of Natural and Health Sciences, Zayed University, Dubai, United Arab Emirates.
Hilda E GhadiehFaculty of Medicine and Medical Sciences, University of Balamand, Tripoli, Lebanon.
Amjad KanaanFaculty of Medicine and Medical Sciences, University of Balamand, Tripoli, Lebanon.
Sami AzarFaculty of Medicine and Medical Sciences, University of Balamand, Tripoli, Lebanon.
Frederic HarbFaculty of Medicine and Medical Sciences, University of Balamand, Tripoli, Lebanon.
University of Balamand · LBZayed University · AE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The intricate interplay of one-carbon metabolism (OCM) with various cellular processes has garnered substantial attention due to its fundamental implications in several biological processes. OCM serves as a pivotal hub for methyl group donation in vital biochemical reactions, influencing DNA methylation, protein synthesis, and redox balance. In the context of aging, OCM dysregulation can contribute to epigenetic modifications and aberrant redox states, accentuating cellular senescence and age-associated pathologies. Furthermore, OCM's intricate involvement in cancer progression is evident through its capacity to provide essential one-carbon units crucial for nucleotide synthesis and DNA methylation, thereby fueling uncontrolled cell proliferation and tumor development. In neurodegenerative disorders like Alzheimer's and Parkinson's, perturbations in OCM pathways are implicated in the dysregulation of neurotransmitter synthesis and mitochondrial dysfunction, contributing to disease pathophysiology. This review underscores the profound impact of OCM in diverse disease contexts, reinforcing the need for a comprehensive understanding of its molecular complexities to pave the way for targeted therapeutic interventions across inflammation, aging and neurodegenerative disorders.

Indexed as

agingAlzheimer’s diseasefolatemitochondrial dysfuntionneurodegenerative diseaseone carbon metabolismParkinson disease

Identifiers

PMID38239489
PMCPMC10794399
OpenAlexW4390584583

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.